Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib

• Main Authors: Haruhiko Otsuka (Author), Takeshi Fukumoto (Author), Naomi Kiyota (Author), Chihiro Takemori (Author), Haruki Jimbo (Author), Chikako Nishigori (Author)
• Format: Book
• Published: PAGEPress Publications, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Regorafenib is an oral multikinase inhibitor targeting several tyrosine kinase receptors including BRAF and epidermal growth factor receptor (EGFR), and is approved as a third-line treatment for metastatic gastrointestinal stromal tumor (GIST). While acneiform eruptions have been observed in patient...